Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

by

CTech 24/7

More stories in CTech

Sanofi

6 stories about Sanofi

“People learn, people develop”: Sanofi Israel’s HR Head sees “only positives” in AI
10.06.25|Amy ShapiroSpeaking with CTech at the Israel Growth Conference, Sanofi Israel’s Katie Kushnir Ventura shared how the pharmaceutical giant is using AI to improve its operations and support employees through upskilling and easier access to digital resources.
Teva’s stock surge comes to a halt, falling 14% amid weak 2025 outlook
30.01.25|Sophie ShulmanDespite a strong 80% gain in 2024, Teva’s stock dropped after the company revealed disappointing profitability and cash flow forecasts.
Teva’s 10-year turnaround takes shape with stunning trial results
18.12.24|Sophie ShulmanDuvakitug signals a brighter future for the Israeli pharma giant.
Teva shares jump as its most promising drug shows exceptional trial results
17.12.24|Sophie ShulmanDuvakitug, designed to treat colitis and Crohn’s disease, exceeded expectations and positions Teva to compete in the $28 billion global market for inflammatory bowel disease treatments.
Nucleai raises $33 million for spatial biology drug development platform
22.03.22|Meir OrbachThe technology developed at the Israeli startup allows better prediction of the patient's response to specific oncological treatment, saves on the ongoing process of testing different drugs and improves the chances of the development of new cancer drugs
Medisafe raises $30 million in Series C led by pharma giant Sanofi
25.02.21|Meir OrbachThe company expanded its platform in 2020 with the launch of Medisafe Care Connector, which digitally connects patients and doctors

About CTech Terms of Use Privacy Policy

Back to Top